Current Clinical Practice in the Management of Atrial Fibrillation in Greece: the MANAGE-AF Study
NCT ID: NCT01317602
Last Updated: 2015-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
603 participants
OBSERVATIONAL
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Atrial Fibrillation With Flecainide : the AFFLEC Study
NCT02190175
Blood Pressure Assessment in Atrial Fibrillation
NCT01088269
Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF)
NCT02213731
BLITZ Atrial Fibrillation
NCT03653598
Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice
NCT05617456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. All patients should give written informed consent to participate in the study.
Exclusion Criteria
2. Participation in an another clinical trial, with the exception of epidemiology trials (observational) that do not influence AF management.
3. Patients with mental disability unable to comply with follow - up visits and these who are unable to provide, in written, their informed consent or patients with anticipated inability to adhere to scheduled follow up visits.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayer
INDUSTRY
Hellenic Cardiovascular Research Society
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Panos E. Vardas, MD, FESC, FACC
Role: PRINCIPAL_INVESTIGATOR
President, Hellenic Cardiovascular Research Society
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Alexandroupoli
Alexandroupoli, , Greece
7th IKA Hospital of Athens
Athens, , Greece
Alexandra Hospital
Athens, , Greece
Euroclinic Athens
Athens, , Greece
General Hospital of Athens Evangelismos
Athens, , Greece
Henry Dunant Hospital
Athens, , Greece
KAT General Hospital
Athens, , Greece
Korgialenio Benakio EES Hospital
Athens, , Greece
Laiko General Hospital
Athens, , Greece
Sismanoglio General Hospital
Athens, , Greece
Ygeia Hospital
Athens, , Greece
General Hospital of Chalkida
Chalcis, , Greece
General Hospital of Chania
Chania, , Greece
General Hospital of Chios
Chios, , Greece
General Hospital of Edessa
Edessa, , Greece
Thriassio General Hospital of Elefsina
Elefsina, , Greece
University Hospital of Heraklion
Heraklion, , Greece
General Hospital Of Heraklio Venizeleio
Heraklio, , Greece
General Hospital of Kavala
Kavala, , Greece
General Hospital of Komotini Sismanoglio
Komotini, , Greece
General Hospital of Ptolemaida Mpodosakeio
Ptolemaida, , Greece
General Hospital of Serres
Serres, , Greece
2nd IKA Hospital of Thessaloniki
Thessaloniki, , Greece
Agios Loukas Clinic
Thessaloniki, , Greece
Ippokrateio Hospital of Thessaloniki
Thessaloniki, , Greece
University Hospital of Thessaloniki AXEPA
Thessaloniki, , Greece
General Hospital of Volos
Volos, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HellenicCardiovascularRS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.